Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Defeit Biotechnology is a high-tech life sciences company based in Chengdu, China, specializing in the development and production of high-quality biological reagents. The company leverages advanced recombinant protein expression platforms and antibody discovery technologies to provide essential raw materials for in vitro diagnostics (IVD) and biomedical research. Their extensive product portfolio includes antigens and antibodies for infectious diseases, tumor markers, cardiac markers, and inflammation indicators. Beyond product sales, Sichuan Defeit offers comprehensive contract research services, including protein engineering, customized antibody development, and assay optimization. The company operates out of the Chengdu Medical City, serving a global clientele of diagnostic manufacturers and pharmaceutical researchers. By focusing on high-purity and high-affinity biological components, Sichuan Defeit supports the advancement of precision medicine and rapid diagnostic testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Defeit.